Literature DB >> 24193276

Chronic diaphyseal osteomyelitis of long bones refractory to conventional therapy - Benefits and risks of reaming of the femoral medullary cavity.

H C Pape1, H Zwipp, G Regel, H Maschek, H Tscherne.   

Abstract

Osteomyelitis of long bones represents a severe complication during fracture healing. If ongoing infection occurs despite reoperation and if antibiotic treatment is of no benefit, reaming of the medullary canal may be beneficial. We investigated the long term follow up (minimum 2 years) of patients submitted to reaming of the medullary canal to evaluate the efficacy of this method. Criteria for successful procedure: no further operative procedure/ antibiotic treatment. 32 patients out of 37 were followed over a 9 year period. Mean incidence of surgical treatment for osteomyelitis prior to reaming: 3.2 operations. Mean duration until reexamination after reaming: 3.7 years. 89% of patients had a full range of motion upon reexamination, in the others further articular injuries were present. 84.3% of patients were working in the same profession as prior to the fracture, 72% were active in sports again, 97% of patients were pain free. One otherwise healthy patient suffering from sclerosing osteitis (Garré) died during reaming of the femur due to bone marrow embolism to the lung. Reaming of the medullary canal has a high rate of curing osteomyelitis even after several previous attempts of surgical revisions and/or antibiotic treatment. The most likely mechanism is based on improvement of local perfusion. During surgery care must be taken not to provoke pulmonary embolization. Intraoperative monitoring by pulmonary artery catheter should performed; reaming should be immediately discontinued, if a rise in pulmonary artery pressure occurs.

Entities:  

Year:  1995        PMID: 24193276     DOI: 10.1007/BF02716217

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  19 in total

1.  Reaming versus non-reaming in medullary nailing: interference with cortical circulation of the canine tibia.

Authors:  M P Klein; B A Rahn; R Frigg; S Kessler; S M Perren
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

2.  [Autologous blood-antibiotic filling as effective therapy of chronic osteomyelitis].

Authors:  L Faupel; K Kunze; H Ecke
Journal:  Unfallchirurgie       Date:  1986-04

3.  [Significance of circulatory disorders for the course of chronic posttraumatic osteomyelitis].

Authors:  E Böhm; W Oelenberg
Journal:  Unfallheilkunde       Date:  1983-11

4.  Infected nonunion of the femur and tibia.

Authors:  P J Kelly
Journal:  Orthop Clin North Am       Date:  1984-07       Impact factor: 2.472

5.  [Comparative morphological, clinical and bacteriological studies in chronic posttraumatic osteomyelitis].

Authors:  E Böhm; K H Müller; G Reissig; F Maas
Journal:  Unfallheilkunde       Date:  1983-02

6.  [Treatment of osteomyelitis with antibiotic cement].

Authors:  G von Foerster; H W Buchholz; H Lodenkämper; U Lodenkämper
Journal:  Chirurg       Date:  1982-11       Impact factor: 0.955

7.  Treatment of nonunion of the tibia with closed and semiclosed intramedullary nailing.

Authors:  J Böhler
Journal:  Clin Orthop Relat Res       Date:  1965 Nov-Dec       Impact factor: 4.176

8.  Treatment of infected pseudarthrosis of the femur and tibia with an interlocking nail.

Authors:  K W Klemm
Journal:  Clin Orthop Relat Res       Date:  1986-11       Impact factor: 4.176

9.  Treatment of infected nonunion and delayed union of tibia fractures with locking intramedullary nails.

Authors:  M E Miller; J R Ada; L X Webb
Journal:  Clin Orthop Relat Res       Date:  1989-08       Impact factor: 4.176

10.  [Medullary reaming in chronic osteomyelitis of the stable femur and tibia shaft].

Authors:  H Zwipp; L Gotzen; N Haas
Journal:  Chirurg       Date:  1984-04       Impact factor: 0.955

View more
  1 in total

Review 1.  The use of Reamer-irrigator-aspirator in the management of long bone osteomyelitis: an update.

Authors:  T H Tosounidis; G M Calori; P V Giannoudis
Journal:  Eur J Trauma Emerg Surg       Date:  2016-07-11       Impact factor: 3.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.